Cargando…
Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer
Advanced castrate-resistant prostate cancer (CRPC) is a poorly prognostic disease currently lacking effective cure. Understanding the molecular mechanism that underlies the initiation and progression of CRPC will provide new strategies for treating this deadly disease. One candidate target is the fi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363687/ https://www.ncbi.nlm.nih.gov/pubmed/30761180 http://dx.doi.org/10.3389/fgene.2019.00012 |